000 | 01365 a2200385 4500 | ||
---|---|---|---|
005 | 20250513111852.0 | ||
264 | 0 | _c19970317 | |
008 | 199703s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNaisbitt, D J | |
245 | 0 | 0 |
_aDisposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cFeb 1997 |
||
300 |
_a884-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmodiaquine _xanalogs & derivatives |
650 | 0 | 4 |
_aAntimalarials _xblood |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aGlutathione _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
650 | 0 | 4 | _aTritium |
700 | 1 | _aRuscoe, J E | |
700 | 1 | _aWilliams, D | |
700 | 1 | _aO'Neill, P M | |
700 | 1 | _aPirmohamed, M | |
700 | 1 | _aPark, B K | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 280 _gno. 2 _gp. 884-93 |
|
999 |
_c9013288 _d9013288 |